Postoperative early recurrence prediction of pancreatic cancer based on CT and pathomics.
1/5 보강
PICO 자동 추출 (휴리스틱, conf 3/4)
유사 논문P · Population 대상 환자/모집단
121 patients with pancreatic ductal adenocarcinoma (PDAC) who underwent radical surgery at our hospital between February 2018 and October 2022 were included in this study.
I · Intervention 중재 / 시술
radical surgery at our hospital between February 2018 and October 2022 were included in this study
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
[CLINICAL TRIAL NUMBER] Not applicable. [SUPPLEMENTARY INFORMATION] The online version contains supplementary material available at 10.1186/s12876-025-04507-5.
[BACKGROUND] Pancreatic cancer (PC) is one of the most aggressive malignancies, with a poor prognosis and a high rate of postoperative recurrence.
- 95% CI 0.681–0.814
APA
Cao W, Li JY, et al. (2025). Postoperative early recurrence prediction of pancreatic cancer based on CT and pathomics.. BMC gastroenterology, 25(1), 894. https://doi.org/10.1186/s12876-025-04507-5
MLA
Cao W, et al.. "Postoperative early recurrence prediction of pancreatic cancer based on CT and pathomics.." BMC gastroenterology, vol. 25, no. 1, 2025, pp. 894.
PMID
41315958 ↗
Abstract 한글 요약
[BACKGROUND] Pancreatic cancer (PC) is one of the most aggressive malignancies, with a poor prognosis and a high rate of postoperative recurrence. Patients with early recurrence typically do not benefit from surgery. Therefore, identifying high-risk patients for early tumor recurrence before surgery is critical for developing personalized treatment strategies. This study is to investigate the clinical value of a multi-scale model, constructed using CT and pathological images, in predicting early recurrence risk following curative surgery for pancreatic cancer.
[METHODS] A total of 121 patients with pancreatic ductal adenocarcinoma (PDAC) who underwent radical surgery at our hospital between February 2018 and October 2022 were included in this study. A retrospective analysis was conducted on the clinical, CT imaging, and histopathological data of all patients, with follow-up until December 2023. Based on clinical factors, radiomics features, and pathomics features, we developed clinical, radiomics, pathomics, and integrated model. A nomogram was generated to visually analyze the integrated model. The optimal cutoff values were determined using X-tile software, and all patients were stratified into high-risk and low-risk groups. Kaplan-Meier survival curves were plotted, and Log-rank tests were performed to assess the significance of survival differences between the groups. The predictive performance of the four models was evaluated using the concordance index (C-index).
[RESULTS] Multivariate Cox regression analyses identified postoperative CA19-9 levels and perineural invasion as independent predictors of early recurrence. The integrated model demonstrated superior predictive performance compared to other individual models, with C-index values of 0.752 (95% CI: 0.681–0.814) in the training cohort and 0.740 (95% CI: 0.680–0.793) in the validation cohort.
[CONCLUSION] The multi-scale integrated model incorporating clinical parameters, radiomics features, and pathomics signatures demonstrates superior predictive accuracy for early recurrence in pancreatic cancer patients, enabling precise risk stratification and supporting personalized adjuvant treatment planning.
[CLINICAL TRIAL NUMBER] Not applicable.
[SUPPLEMENTARY INFORMATION] The online version contains supplementary material available at 10.1186/s12876-025-04507-5.
[METHODS] A total of 121 patients with pancreatic ductal adenocarcinoma (PDAC) who underwent radical surgery at our hospital between February 2018 and October 2022 were included in this study. A retrospective analysis was conducted on the clinical, CT imaging, and histopathological data of all patients, with follow-up until December 2023. Based on clinical factors, radiomics features, and pathomics features, we developed clinical, radiomics, pathomics, and integrated model. A nomogram was generated to visually analyze the integrated model. The optimal cutoff values were determined using X-tile software, and all patients were stratified into high-risk and low-risk groups. Kaplan-Meier survival curves were plotted, and Log-rank tests were performed to assess the significance of survival differences between the groups. The predictive performance of the four models was evaluated using the concordance index (C-index).
[RESULTS] Multivariate Cox regression analyses identified postoperative CA19-9 levels and perineural invasion as independent predictors of early recurrence. The integrated model demonstrated superior predictive performance compared to other individual models, with C-index values of 0.752 (95% CI: 0.681–0.814) in the training cohort and 0.740 (95% CI: 0.680–0.793) in the validation cohort.
[CONCLUSION] The multi-scale integrated model incorporating clinical parameters, radiomics features, and pathomics signatures demonstrates superior predictive accuracy for early recurrence in pancreatic cancer patients, enabling precise risk stratification and supporting personalized adjuvant treatment planning.
[CLINICAL TRIAL NUMBER] Not applicable.
[SUPPLEMENTARY INFORMATION] The online version contains supplementary material available at 10.1186/s12876-025-04507-5.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Hypoxia-induced exosomal circ_0006840 promotes pancreatic cancer progress by regulating the WIF1 decay.
- Combining network pharmacology and transcriptomics to validate and explore Shenqiyichang decoction in treating colorectal cancer by NQO1 inhibition, ROS activation and Wnt/β-catenin signaling pathway.
- Nanoliposomal PD-1 antagonist target tumor-draining lymph nodes to revitalize T cells and improve anti-tumor effect in hepatocellular carcinoma.
- Effect and mechanism of the miR-1284/EIF4A1 axis on the cGAS-STING pathway under radiotherapy.
- Correction: Nanoliposomal PD-1 antagonist target tumor-draining lymph nodes to revitalize T cells and improve anti-tumor effect in hepatocellular carcinoma.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Machine learning integrating MRI and clinical features predicts early recurrence of hepatocellular carcinoma after resection.
- Racial Disparities in Pancreatic Cancer: A Comprehensive Population-Based Analysis of Survival, Surgical Access, and Prognostic Factors.
- Engineering NKG2D ligand affinity transforms EGFR-targeted NK cell engagers into high-potency effectors against pancreatic cancer.
- A Transformer-Based Deep Learning Model for predicting Early Recurrence in Hepatocellular Carcinoma After Hepatectomy Using Intravoxel Incoherent Motion Images.
- Cell Culture Substrate Variation Alters Extracellular Vesicle Biogenesis Without Affecting Non-Coding Repeat RNA Profile.
- Classification of Pancreatic Cancer and Normal Tissue in 2D and 3D Optical Coherence Tomography Images Using Convolutional Neural Networks: A Comparative Study.